Akèy › Melanom › Alabama › Birmingham
Etid klinik pou Melanom nan Birmingham, AL
11 etid pou Melanom ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
- Research Site, Birmingham
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Ap rekriteFaz 3
- University of Alabama at Birmingham: The Kirklin Clinic, Birmingham
Pan-tumor MRD Study
Ap rekriteEtid obsèvasyon
- Alabama Oncology, Birmingham
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Ap rekriteFaz 3
- University of Alabama at Birmingham Cancer Center, Birmingham
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Ap rekriteFaz 2
- University of Alabama at Birmingham Cancer Center, Birmingham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Ap rekriteEtid obsèvasyon
- University of Alabama at Birmingham, Birmingham
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
Ap rekriteFaz 1/2
- The University of Alabama at Birmingham, Birmingham
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Ap rekriteFaz 1/2
- Children's Hospital of Alabama, Birmingham
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- Children's Hospital of Alabama, Birmingham
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Ap rekrite
- University of Alabama at Birmingham, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Birmingham
Etid Melanom nan lòt vil
- Houston, TX59 etid
- New York City, NY38 etid
- Los Angeles, CA34 etid
- Nashville, TN33 etid
- Pittsburgh, PA31 etid
- Boston, MA26 etid
- Philadelphia, PA23 etid
- San Francisco, CA22 etid
- Durham, NC21 etid
- Atlanta, GA21 etid
- St. Louis, MO21 etid
- Salt Lake City, UT21 etid
Lòt etid nan Birmingham
- Kansè (tout kalite)30 etid
- Kansè nan tete24 etid
- Obèsite23 etid
- Kansè ovè23 etid
- Kansè Poumon ki pa ti selil22 etid
- Leksemi mieloïd egi21 etid
- Myelom Miltip18 etid
- BPCO17 etid
- Maladi kadyovaskilè17 etid
- Sipwa16 etid
- Kansè Endomèt16 etid
- Dyabèt Tip 216 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.